|
|
 |
|
Viewing report
|
|
|
|
Bristol-Myers Squibb Company: SWOT Analysis & Company Profile
Business Review, Nov 2010, Pages: 25
Synopsis
Business Review’s Bristol-Myers Squibb Company contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Bristol-Myers Squibb Company’s business.
Business Review’s “Bristol-Myers Squibb Company SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Bristol-Myers Squibb Company) for business intelligence requirements
- Studies and presents Bristol-Myers Squibb Company’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacture, marketing and distribution of biopharmaceuticals and related healthcare products. Its principal focus areas include cancer, infectious diseases, psychiatry disorders, cardiovascular and metabolic disorders and immune disorders. The company operates through a single reportable business segment, Biopharmaceuticals. It focuses on research and development (R&D) activities to develop innovative medicines for the treatment of serious diseases. BMS has its presence in various countries throughout the world. The company is headquartered in New York, the US.
|
|
|
|
